Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex Grant US-11925676-B2 United States of America 12 Mar 2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-RE49847-E1 United States of America 27 Feb 2024
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells Grant US-11896616-B2 United States of America 13 Feb 2024
Method of treating cancer with composition comprising IL-15-based molecules and BCG Grant US-11890323-B2 United States of America 06 Feb 2024
Method of treating cancer by administering immune effector cells expressing a chimeric… Grant US-11872249-B2 United States of America 16 Jan 2024
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11851491-B2 United States of America 26 Dec 2023
Multimeric IL-15 soluble fusion molecules and methods of making and using same Grant US-11845783-B2 United States of America 19 Dec 2023
Compositions and methods for treating cancer with DuoCARs Grant US-11802142-B2 United States of America 31 Oct 2023
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy Grant US-11680103-B2 United States of America 20 Jun 2023
IL-15-based molecules and methods of use thereof Grant US-11679144-B2 United States of America 20 Jun 2023
Methods and compositions for treating cancer Grant US-11649438-B2 United States of America 16 May 2023
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11622977-B2 United States of America 11 Apr 2023
METHODS FOR MAKING AND USING THERAPEUTIC CELLS Application WO-2023056373-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2023
Chimeric antigen receptors based on alternative signal 1 domains Grant US-11578115-B2 United States of America 14 Feb 2023
Immune cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof Grant US-11560548-B2 United States of America 24 Jan 2023
Methods and compositions relating to chimeric antigen receptors Grant US-11530252-B2 United States of America 20 Dec 2022
IL-15-based molecules and methods of use thereof Grant US-11471511-B2 United States of America 18 Oct 2022
COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATIONS THEREOF Application EP-3989986-A4 European Patent Office 12 Oct 2022
Compositions and methods for treating cancer with DuoCARs Grant US-11453712-B2 United States of America 27 Sep 2022
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant US-11439665-B2 United States of America 13 Sep 2022
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells… Grant US-11389481-B2 United States of America 19 Jul 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11377638-B2 United States of America 05 Jul 2022
Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapy Grant US-11365236-B2 United States of America 21 Jun 2022
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11298378-B2 United States of America 12 Apr 2022
CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT Application EP-3752170-A4 European Patent Office 30 Mar 2022
CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19 Application EP-3793578-A4 European Patent Office 23 Mar 2022
Methods and compositions for treating cancer Grant US-11254912-B2 United States of America 22 Feb 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11242376-B2 United States of America 08 Feb 2022
METHODS AND COMPOSITIONS RELATING TO ENGINEERED REGULATORY T CELLS Application EP-3697820-A4 European Patent Office 05 Jan 2022
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant US-11207349-B2 United States of America 28 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11207351-B2 United States of America 28 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11202802-B2 United States of America 21 Dec 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11191783-B2 United States of America 07 Dec 2021
IL-15-based molecules and methods of use thereof Grant US-11173191-B2 United States of America 16 Nov 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11166985-B2 United States of America 09 Nov 2021
CELL CLASSIFIER CIRCUITS AND METHODS OF USE THEREOF Application WO-2021209813-A2 World Intellectual Property Organisation (WIPO) 21 Oct 2021
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen… Grant US-11149076-B2 United States of America 19 Oct 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology Grant US-11135247-B2 United States of America 05 Oct 2021
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Application US-20210290673-A1 United States of America 23 Sep 2021
COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATIONS THEREOF Application WO-2021188681-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same Grant US-11104716-B2 United States of America 31 Aug 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11085021-B2 United States of America 10 Aug 2021
Multimeric IL-15 soluble fusion molecules and methods of making and using same Grant US-11046747-B2 United States of America 29 Jun 2021
Bicistronic chimeric antigen receptor targeting CD19 and CD20 and uses thereof Application CN-112955172-A China 11 Jun 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11028142-B2 United States of America 08 Jun 2021
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-11026976-B2 United States of America 08 Jun 2021
Chimeric antigen receptor targeting the tumor microenvironment Application JP-2021512635-A Japan 20 May 2021
ULTRAMODULAR IGG3-BASED SPACER DOMAIN AND MULTI-FUNCTION SITE FOR IMPLEMENTATION IN… Application WO-2020254591-A1 World Intellectual Property Organisation (WIPO) 24 Dec 2020
LOCKR-MEDIATED RECRUITMENT OF CAR T CELLS Application WO-2020232447-A1 World Intellectual Property Organisation (WIPO) 19 Nov 2020
Natural killer cells modified to express membrane-bound interleukin 15 and uses thereof Grant US-10774311-B2 United States of America 15 Sep 2020
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-10525083-B2 United States of America 07 Jan 2020
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy Application US-10442867-B2 United States of America 15 Oct 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10442849-B2 United States of America 15 Oct 2019
ADHESION RECEPTOR CONSTRUCTS AND USES THEREOF IN NATURAL KILLER CELL IMMUNOTHERAPY Application WO-2019155286-A3 World Intellectual Property Organisation (WIPO) 26 Sep 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358474-B2 United States of America 23 Jul 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358473-B2 United States of America 23 Jul 2019
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen… Grant US-10253086-B2 United States of America 09 Apr 2019
A kind of pair of targeting Chimeric antigen receptor and application thereof Application CN-109423495-A China 05 Mar 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10208285-B2 United States of America 19 Feb 2019
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD20 IMMUNOTHERAPY Application WO-2019028051-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2019
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN… Application WO-2016164731-A3 World Intellectual Property Organisation (WIPO) 10 Nov 2016